Heterogeneous decrease of bone mineral density in the vertebral column of ovariectomized rats. 1995

C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
Departamento de Fisiología y Farmacología, Universidad de Salamanca, Spain.

The long-term effect of ovariectomy on the loss of bone mineral density (BMD) was evaluated in rats with and without estrogen treatment; BMD was studied in the lumbar and caudal vertebrae, measured by DXA, to find how the losses of BMD occur in the axial skeleton. Seventy female Wistar rats of 3 months of age were divided into four groups as follows: group 1: control animals; group 2: ovariectomized animals; group 3: ovariectomized animals undergoing treatment with estrogen (0.25 mg/kg per week of 17-beta estradiol); group 4: ovariectomized rats undergoing estrogen treatment only during the last 3 months of the experimental period. No significant differences were found among the groups in regard to the BMD values of the caudal vertebrae at either 3 or 6 months. Likewise, in the lumbar vertebrae there were no significant differences among the groups after 3 months. However, at 6 months, a decrease in the BMDs of the ovariectomized animals with respect to the remaining groups was found: 226 +/- 11 mg/cm2 in the ovariectomized group; 262 +/- 14 mg/cm2 in the controls; 255 +/- 4 mg/cm2 in the rats receiving estrogen treatment for 6 months; and 259 +/- 5 mg/cm2 in the animals receiving estrogen for 3 months. The study also reveals the absence of differences in the bone mineral density between the ovariectomized and control rats when the former received estrogen treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008159 Lumbar Vertebrae VERTEBRAE in the region of the lower BACK below the THORACIC VERTEBRAE and above the SACRAL VERTEBRAE. Vertebrae, Lumbar
D010052 Ovariectomy The surgical removal of one or both ovaries. Castration, Female,Oophorectomy,Bilateral Ovariectomy,Bilateral Ovariectomies,Castrations, Female,Female Castration,Female Castrations,Oophorectomies,Ovariectomies,Ovariectomies, Bilateral,Ovariectomy, Bilateral
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D001846 Bone Development The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS. Bone Growth
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen

Related Publications

C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
December 1996, Bone,
C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
January 2008, Journal of bone and mineral metabolism,
C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
December 2015, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
November 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
July 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
January 2009, Advances in experimental medicine and biology,
C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
June 1993, Calcified tissue international,
C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
November 1995, Nihon Seikeigeka Gakkai zasshi,
C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
June 2014, Zhongguo shi yan xue ye xue za zhi,
C García-Moreno, and O M Calvo, and S Herrero, and E Martín, and B Suquía, and J I San Román, and M Martín, and J R García-Talavera, and J J Calvo, and J del Pino
December 2001, Clinical oral implants research,
Copied contents to your clipboard!